| Entry |
|
|---|
| Name |
Fomivirsen (INN) |
|---|
| Abbr |
FMV |
|---|
| Formula |
C204H243N63O114P20S20
|
|---|
| Exact mass |
6657.4321
|
|---|
| Mol weight |
6662.2412
|
|---|
| Class |
Antiviral
DG01937 Anti-cytomegalovirus agent
|
|---|
| Remark |
| Chemical structure group: | DG01125 |
|
|---|
| Efficacy |
Antiviral, Translation inhibitor |
|---|
| Comment |
Antisense oligonucleotide
Therapy of cytomegalovirus retinitis
|
|---|
| Target |
HCMV IE2 [KO:K22775] (mRNA) |
|---|
| Pathway |
| ko05163 | Human cytomegalovirus infection |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07044 | Antiviral agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01A ANTIINFECTIVES
S01AD Antivirals
S01AD08 Fomivirsen
D07989 Fomivirsen (INN)
Drug groups [BR:br08330]
Antiviral
DG01937 Anti-cytomegalovirus agent
DG01125 Fomivirsen
D07989 Fomivirsen
Antimicrobials [BR:br08307]
Antivirals
Polyprotein cleavage inhibitor
HCMV IE2 antisense
D07989 Fomivirsen (INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Polyprotein cleavage inhibitor
HCMV IE2 antisense
D07989 Fomivirsen (INN)
Drug groups [BR:br08330]
Antiviral
DG01937 Anti-cytomegalovirus agent
DG01125 Fomivirsen
|
|---|
| Other DBs |
|
|---|